Loading…
Loading…
ACBM does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for ACBM and 80,000+ other tickers.
See exactly how ACBM's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for ACBM and 80,000+ other tickers.
Acro Biomedical Co., Ltd. focuses on the development and commercialization of dietary supplements. The company offers products such as cordycepin and powdered cordyceps, which come from a type of fungus traditionally utilized in Chinese medicinal practices. Originally founded in 2014, the organization was known as Killer Waves Hawaii, Inc. until it rebranded as Acro Biomedical Co., Ltd. in January 2017. Its operations are headquartered in Fishers, Indiana.
No recent news available.